1,5-anhydroglucitol has been researched along with c-peptide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Akanuma, H; Akanuma, Y; Akaoka, I; Asano, T; Konishi, C; Yamanouchi, T | 1 |
| Abramczyk, M; Borowska, M; Dworacka, M; Kuczynski, S; Szczawinska, K; Winiarska, H | 1 |
| Bobkiewicz-Kozłowska, T; Dworacka, M; Wegner, M; Winiarska, H | 1 |
| Hamano, K; Ishibashi, S; Kiyono, K; Kusaka, I; Nagasaka, S; Ogata, H; Struzik, ZR; Suzuki, H; Tokuyama, K; Tsuchita, T; Yamada, N; Yamamoto, Y | 1 |
| Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K | 1 |
| Burger, D; Faustman, DL; Hsu, E; Kuhtreiber, WM; Reinhold, P; Washer, SL; Zhao, M; Zheng, H | 1 |
| Kadowaki, T; Muto, S; Ouchi, Y; Seino, Y; Shimazaki, R | 1 |
| Bao, Y; Hu, G; Lu, J; Lu, W; Ma, X; Mo, Y; Shen, Y; Si, Y; Zhang, L; Zhou, J; Zhu, W | 1 |
4 trial(s) available for 1,5-anhydroglucitol and c-peptide
| Article | Year |
|---|---|
Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
Topics: Aged; Blood Glucose; Body Mass Index; C-Peptide; Caloric Restriction; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Multivariate Analysis; Patient Selection; Proinsulin; Sulfonylurea Compounds | 2006 |
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).
Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin | 2012 |
Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.
Topics: Adamantane; Aged; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Placebo Effect; Treatment Outcome | 2017 |
Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin-Secreting Cells; Male; Middle Aged; Pancreatic Function Tests; Predictive Value of Tests | 2020 |
4 other study(ies) available for 1,5-anhydroglucitol and c-peptide
| Article | Year |
|---|---|
Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blood Glucose; C-Peptide; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Middle Aged; Rats | 1987 |
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin-12; Lipoproteins, HDL; Male; Middle Aged; Multivariate Analysis; Proinsulin; Regression Analysis; Sulfonylurea Compounds | 2008 |
The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Serum Albumin | 2012 |
Low levels of C-peptide have clinical significance for established Type 1 diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Child; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Glycated Hemoglobin; Humans; Middle Aged; Prognosis; Young Adult | 2015 |